Literature DB >> 33587450

mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion Patterns.

Sheila Segura1, Simona Stolnicu2, Monica Boros3, Kay Park4, Pedro Ramirez5, Gloria Salvo5, Denise Frosina4, Achim Jungbluth4, Robert A Soslow4.   

Abstract

The Silva pattern of invasion, recently introduced to stratify patients at risk for lymph node metastases in human papillomavirus-associated endocervical adenocarcinomas (HPVAs), can only be assessed in cone and loop electrosurgical excision procedure excisions with negative margins or in a hysterectomy specimen. Previous studies found associations between destructive stromal invasion patterns (Silva patterns B and C) and mutations in genes involved in the MEK/PI3K pathways that activate the mammalian target of rapamycin (mTOR) pathway. The primary aim of this study was to use cervical biopsies to determine whether markers of mTOR pathway activation associate with aggressive invasion patterns in matched excision specimens. The status of the markers in small biopsy specimens should allow us to predict the final and biologically relevant pattern of invasion in a resection specimen. Being able to predict the final pattern of invasion is important, since prediction as Silva A, for example, might encourage conservative clinical management. If the pattern in the resection specimen is B with lymphovascular invasion or C, further surgery can be performed 34 HPVA biopsies were evaluated for expression of pS6, pERK, and HIF1α. Immunohistochemical stains were scored semiquantitatively, ranging from 0 to 4+ with scores 2 to 4+ considered positive, and Silva pattern was determined in follow-up excisional specimens. Silva patterns recognized in excisional specimens were distributed as follows: pattern A (n=8), pattern B (n=4), and pattern C (n=22). Statistically significant associations were found comparing pS6 and pERK immunohistochemistry with Silva pattern (P=0.034 and 0.05, respectively). Of the 3 markers tested, pERK was the most powerful for distinguishing between pattern A and patterns B and C (P=0.026; odds ratio: 6.75, 95% confidence interval: 1.111-41.001). Although the negative predictive values were disappointing, the positive predictive values were encouraging: 90% for pERK, 88% for pS6 and 100% for HIF1α. mTOR pathway activation assessed by immunohistochemistry in cervical biopsies of HPVA correlate with Silva invasion patterns.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33587450      PMCID: PMC8349934          DOI: 10.1097/PAI.0000000000000915

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  39 in total

Review 1.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress.

Authors:  Ira Tabas; David Ron
Journal:  Nat Cell Biol       Date:  2011-03       Impact factor: 28.824

2.  Interobserver variability in the application of a proposed histologic subclassification of endocervical adenocarcinoma.

Authors:  Cherie Paquette; Susanne K Jeffus; Charles M Quick; Mark R Conaway; Mark H Stoler; Kristen A Atkins
Journal:  Am J Surg Pathol       Date:  2015-01       Impact factor: 6.394

3.  Landscape of genomic alterations in cervical carcinomas.

Authors:  Akinyemi I Ojesina; Lee Lichtenstein; Samuel S Freeman; Chandra Sekhar Pedamallu; Ivan Imaz-Rosshandler; Trevor J Pugh; Andrew D Cherniack; Lauren Ambrogio; Kristian Cibulskis; Bjørn Bertelsen; Sandra Romero-Cordoba; Victor Treviño; Karla Vazquez-Santillan; Alberto Salido Guadarrama; Alexi A Wright; Mara W Rosenberg; Fujiko Duke; Bethany Kaplan; Rui Wang; Elizabeth Nickerson; Heather M Walline; Michael S Lawrence; Chip Stewart; Scott L Carter; Aaron McKenna; Iram P Rodriguez-Sanchez; Magali Espinosa-Castilla; Kathrine Woie; Line Bjorge; Elisabeth Wik; Mari K Halle; Erling A Hoivik; Camilla Krakstad; Nayeli Belem Gabiño; Gabriela Sofia Gómez-Macías; Lezmes D Valdez-Chapa; María Lourdes Garza-Rodríguez; German Maytorena; Jorge Vazquez; Carlos Rodea; Adrian Cravioto; Maria L Cortes; Heidi Greulich; Christopher P Crum; Donna S Neuberg; Alfredo Hidalgo-Miranda; Claudia Rangel Escareno; Lars A Akslen; Thomas E Carey; Olav K Vintermyr; Stacey B Gabriel; Hugo A Barrera-Saldaña; Jorge Melendez-Zajgla; Gad Getz; Helga B Salvesen; Matthew Meyerson
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

4.  Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists.

Authors:  Carlos Parra-Herran; Monica Taljaard; Bojana Djordjevic; M Carolina Reyes; Lauren Schwartz; John K Schoolmeester; Ricardo R Lastra; Charles M Quick; Anna Laury; Golnar Rasty; Marisa R Nucci; Brooke E Howitt
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

5.  Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway.

Authors:  Hong Lou; Guillermo Villagran; Joseph F Boland; Kate M Im; Sarita Polo; Weiyin Zhou; Ushie Odey; Eligia Juárez-Torres; Ingrid Medina-Martínez; Edgar Roman-Basaure; Jason Mitchell; David Roberson; Julie Sawitzke; Lisa Garland; Maria Rodríguez-Herrera; David Wells; Jennifer Troyer; Francisco Castillo Pinto; Sara Bass; Xijun Zhang; Miriam Castillo; Bert Gold; Hesler Morales; Meredith Yeager; Jaime Berumen; Enrique Alvirez; Eduardo Gharzouzi; Michael Dean
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

Review 6.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

7.  Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.

Authors:  Alexi A Wright; Brooke E Howitt; Andrea P Myers; Suzanne E Dahlberg; Emanuele Palescandolo; Paul Van Hummelen; Laura E MacConaill; Melina Shoni; Nikhil Wagle; Robert T Jones; Charles M Quick; Anna Laury; Ingrid T Katz; William C Hahn; Ursula A Matulonis; Michelle S Hirsch
Journal:  Cancer       Date:  2013-08-23       Impact factor: 6.860

8.  mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.

Authors:  Patricia Freis; Julien Bollard; Justine Lebeau; Patrick Massoma; Joëlle Fauvre; Cécile Vercherat; Thomas Walter; Serge Manié; Colette Roche; Jean-Yves Scoazec; Carole Ferraro-Peyret
Journal:  Oncotarget       Date:  2017-03-28

9.  The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Isabel Alvarado-Cabrero; Carlos Parra-Herran; Simona Stolnicu; Andres Roma; Esther Oliva; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

10.  Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer.

Authors:  Y Zhou; Y Pan; S Zhang; X Shi; T Ning; Y Ke
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.